Description | This publication offers insight and commentary regarding the defense of pharmaceutical and medical device product liability litigation. |
h1 tags | Drug & Device Law Guest Post – Fraudulent Joinder Of Defendant With No Connection To The Plaintiff Cannot Forestall Foray To Zantac MDL Unusual Indictment of MDL Practices More Mesh Mess Irrelevant and Prejudicial Long-Ago Evidence Excluded in IVC Filter Case OTC – One Terrible Class Action – Dismissed When the Law Isn’t Really the Law – Creative Jurisprudence in Mostly Bad C.D. California Singulair Decision Comment K, Presumptions, and Medical Device Design Defects Under Texas Law EDNY Holds Glucosamine Claims Preempted Good Prescriber Testimony Plus Bad Expert Testimony Equals Another One-Two Punch Logical Contradiction Doctrine: Buckman for Textualists California Reaffirms Healthcare Data Privacy Standard And Rejects Class Certification Litigation Over COVID-19 Policies Continues Bard IVC Filters MDL Denies Request for Exemption from Common Benefit Fund Assessments Learned Intermediary — Not an Affirmative Defense in California Drug & Device Law |
h2 tags | Your page doesn't have H2 tags. |
Site Speed | 0.85897898674011 |
Alexa Rank: |
0 |
Site's Traffic |
Host | Type | Class | TTL | Target |
druganddevicelawblog.com | HINFO | IN | 3789 |